Concord Medical Services Holdings Past Earnings Performance
Past criteria checks 0/6
Concord Medical Services Holdings's earnings have been declining at an average annual rate of -2.7%, while the Healthcare industry saw earnings declining at 0.8% annually. Revenues have been growing at an average rate of 27.1% per year.
Key information
-2.7%
Earnings growth rate
-2.6%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 27.1% |
| Return on equity | -30.4% |
| Net Margin | -55.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Concord Medical Services Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 537 | -298 | 386 | 0 |
| 30 Sep 23 | 575 | -382 | 389 | 0 |
| 30 Jun 23 | 612 | -466 | 392 | 0 |
| 31 Mar 23 | 542 | -478 | 382 | 0 |
| 31 Dec 22 | 472 | -490 | 373 | 0 |
| 30 Sep 22 | 455 | -667 | 372 | 0 |
| 30 Jun 22 | 437 | -845 | 372 | 0 |
| 31 Mar 22 | 461 | -833 | 387 | 0 |
| 31 Dec 21 | 486 | -821 | 401 | 0 |
| 30 Sep 21 | 409 | -726 | 376 | 0 |
| 30 Jun 21 | 333 | -631 | 350 | 0 |
| 31 Mar 21 | 278 | -651 | 335 | 0 |
| 31 Dec 20 | 223 | -670 | 321 | 0 |
| 30 Sep 20 | 202 | -606 | 336 | 0 |
| 30 Jun 20 | 182 | -541 | 352 | 0 |
| 31 Mar 20 | 190 | -547 | 348 | 0 |
| 31 Dec 19 | 198 | -553 | 345 | 0 |
| 30 Sep 19 | 192 | -462 | 342 | 0 |
| 30 Jun 19 | 185 | -371 | 339 | 0 |
| 31 Mar 19 | 188 | -365 | 326 | 0 |
| 31 Dec 18 | 191 | -359 | 314 | 0 |
| 30 Sep 18 | 210 | -335 | 287 | 0 |
| 30 Jun 18 | 230 | -311 | 260 | 0 |
| 31 Mar 18 | 280 | -297 | 271 | 0 |
| 31 Dec 17 | 331 | -284 | 281 | 0 |
| 30 Sep 17 | 369 | -299 | 293 | 0 |
| 30 Jun 17 | 407 | -313 | 305 | 0 |
| 31 Mar 17 | 433 | -281 | 289 | 0 |
| 31 Dec 16 | 455 | -262 | 276 | 0 |
| 30 Sep 16 | 492 | -322 | 273 | 0 |
| 30 Jun 16 | 546 | -194 | 256 | 0 |
| 31 Mar 16 | 591 | -139 | 259 | 0 |
| 31 Dec 15 | 616 | -78 | 246 | 0 |
| 30 Sep 15 | 405 | 96 | 198 | 0 |
| 30 Jun 15 | 504 | 104 | 168 | 0 |
| 31 Mar 15 | 615 | 102 | 154 | 0 |
| 31 Dec 14 | 607 | 99 | 149 | 0 |
| 30 Sep 14 | 552 | 91 | 169 | 0 |
| 30 Jun 14 | 1,061 | 99 | 208 | 0 |
| 31 Mar 14 | 502 | 81 | 190 | 0 |
| 31 Dec 13 | 563 | 75 | 189 | 0 |
| 30 Sep 13 | 905 | 107 | 173 | 0 |
Quality Earnings: C2C is currently unprofitable.
Growing Profit Margin: C2C is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: C2C is unprofitable, and losses have increased over the past 5 years at a rate of 2.7% per year.
Accelerating Growth: Unable to compare C2C's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: C2C is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (13.2%).
Return on Equity
High ROE: C2C has a negative Return on Equity (-30.4%), as it is currently unprofitable.